Sign in

CIK 0001404281

  • Non-accelerated filer
  • Smaller reporting company

Eledon Pharmaceuticals, Inc.

Sign in to watch
Ticker
ELDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 949-238-8090
Business address
19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
Former names
Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-03-19 FLESHER GREGORY J. Chief Executive Officer Grant or award · Stock Option (Right to Buy) +200,000 200,000
2019-09-26 FLESHER GREGORY J. Chief Executive Officer Grant or award · Stock Option (Right to Buy) +100,000 100,000
2019-05-21 FLESHER GREGORY J. Chief Executive Officer Sale −2,937 $1.91 $6K 156,918
2019-05-20 FLESHER GREGORY J. Chief Executive Officer Sale −11,701 $1.96 $23K 159,855
2019-03-14 FLESHER GREGORY J. Chief Executive Officer Grant or award +25,000 171,556
2019-03-14 FLESHER GREGORY J. Chief Executive Officer Grant or award · Stock Option (Right to Buy) +90,000 90,000
2018-03-13 FLESHER GREGORY J. Chief Executive Officer Grant or award +30,700 146,556
2018-03-13 FLESHER GREGORY J. Chief Executive Officer Grant or award · Stock Option (Right to Buy) +56,500 56,500
2017-05-24 FLESHER GREGORY J. Chief Executive Officer Grant or award · Stock Option (Right to Buy) +250,000 250,000
2017-05-10 FLESHER GREGORY J. Chief Executive Officer Purchase +58,959 $9.99 $589K 115,856

Page 1 of 1 · 10 trades